1. Stass H, Dalhoff A, Kubitza D, Schuhly U (1998) Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects. Antimicrobial Agents and Chemotherapy 42:2060–2065
2. Stass H, Kubitza D (1998) Cross over study to assess the absolute bioavailability and absorption characteristics of BAY 12–8039. In: Programme and Abstracts of the Eight International Conference of Infectious Diseases, Boston, MA
3. Stass H, Delesen H, Kubitza D (1998) Determination of excretion patterns of BAY 12–8039 following single oral and intravenous doses. In: Programme and Abstracts of the Eight Inter-national Conference on Infectious Diseases, Boston, MA
4. Andrews J, Honeybourne D, Jevons G, Wise R (1998) Penetration of moxifloxacin into bronchial mucosa, epithelial lining fluid and alveolar macrophages following a single 400 mg oral dose. In: International Congress of Antimicrobial Agents and Chemotherapy, Abstract A29